The Clinical Translation and Commercialisation - Medtech (CTCM) program, delivered by MTPConnect, is offered under the 2020 Early Stage Translation and Commercialisation Support Grant of the Medical Research Future Fund's Medical Research Commercialisation Initiative. The $19.75 million CTCM program is targeting Australian small to medium-sized enterprises (SMEs) and aims to boost commercialisation of home-grown medical devices.

The CTCM program can provide between $250,000 and $1.5 million to SMEs to support early clinical development of medical devices with commercial potential. The first funding round of our CTCM program is  open for applications until 11 March 2022. If you missed the Information Session webinar, listen to it here to see if your company is eligible for funding support. 

Hear from MTPConnect's Dr Duncan Macinnis, MTAA's Ian Burgess, MDPP's Dr Andrew Milligan and Cicada Innovation's Dr Dharmica Mistry on applying for funds to develop medical devices.